Watson L6-8 Flashcards

1
Q

What was the history of diabetes?

A
  • Ancient Hindu manuscripts > 2000y ago – described urine
  • Sushruta – Hindu physician
    400 BC – tasted urine and noticed sweetness due to sugar being present. First highlighted due to presence of flies.
  • ~250 BC – “diabetes” = “to syphon”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who were the influential people who helped discover diabetes?

A

Thomas Willis, von Merking & Minkowski, Banting & Best.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What was the role of Thomas Willis?

A

He was physician to King Charles II. “Diabetes Mellitus” having the taste of urine – honey and sugar. 1869 – Langerhans describes some odd looking groups of cells in the pancreas – about 1-2 % of total cells labelled Islets of Langerhans.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What was the role of von Merking & Minkowski in diabetes?

A

They were actually studying lipid metabolism and suspected the pancreas played a role (through bile secretion). Removed dog pancreas. They removed the pancreas and had to leave town for a few days. On their return the dog was exhibiting all the symptoms of diabetes!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What was the role of the Banting and Best in diabetes?

A

Tied off the pancreas and collected accumulated “extract.” His professor told him that his attempts were futile. First isolation of “insulin.” A polypeptide hormone that controlled circulating levels of glucose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is insulin synthesised?

A

Synthesised in pancreatic beta cells as preproinsulin. Proteolytically cleaved to generate two chains joined by disulphide bonds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What chain is insulin involved in?

A

Negative feedback chain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the opposing hormone to insulin?

A

Glucagon. It is released by pancreatic alpha cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the two main forms of diabetes?

A
  1. Type 1 DM – Typically adolescent onset called “juvenile diabetes.” Catastrophic loss of mass with an absolute requirement for insulin.
  2. Type 2 DM – Typically maturity onset. May not require insulin and can be modified by diet and exercise.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the components of the glucose system?

A

Kir 6.2 an ATP gated inwardly rectifying K+ channel, KATP, L-type Ca2+ channel which is voltage dependent, GLUT-2 glucose transporter and hexokinase IV (glucokinase).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the structure of glucagon and what is its role?

A

Glucagon is a 29 aa peptide hormone with opposite actions of insulin and increase circulatory glucose. It increases gluconeogenesis (makes glucose from Acetyl CoA in liver) and increases glycogenolysis. Decreases lipogenesis (formation of fatty acids from Acetyl CoA).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is glucagon released?

A

Glucagon release by a-cells is also controlled by ADP/ATP levels and glucose metabolism by mitochondria. Release of glucagon is triggered by low cellular glucose levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What do pancreatic islets contain?

A

Clusters of pancreatic alpha and beta cells. Pancreatic a produce hormone glucagon. Pancreatic b are the site of insulin production. Endocrine tissue release the hormones into the circulation by diffusion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the beta cell function?

A

Glucose enters cells via GLUT-2. Glucose is phosphorylated by Hexokinase IV. G6P metabolised by mitochondria altering levels of ATP in the cell. ATP/ADP ratio act as sensor for circulating glucose levels. Increased ATP closes the K+ channel causing cell depolarisation. Collapse of membrane potential activates the voltage-sensitive Ca2+ channel. Influx of Ca2+. Ca2+ flux drives membrane fusion of secretory granules and release of insulin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is alpha cell function?

A

Alpha cells exhibit depolarisation/ triggering activity under conditions of low ATP. The K leakage current is low enough to trigger depolarisation. Paradoxically - blocking K channel with increased ATP actually reduces triggering.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is the insulin signal induced?

A

Phosphorylation of insulin receptor activates serine/threonine kinases. Leads to phosphorylation of a series of insulin-receptor-substrates (IRS). Phosphorylation of IRS-1/ IRS-2 activates the phosphoinositol pathway. Leading to phosphorylation and activation of Akt (protein kinase B). Akt is the main mediator of metoblic actions of insulin. Akt signalling drives cytoskeleton rearrangements that lead to insertion/activation of high affinity transporter GLUT4. Increases uptake of glucose 20 fold. Uptake of circulating glucose by skeletal muscle and adipocytes. Reduces blood levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the effects of insulin?

A

In the liver
o Decreased gluconeogenesis
o Increased glycogenesis
o Decreased glycogenolysis
o Increase lipogenesis
In the pancreas
o Decreased glucagon
o Increased beta cell growth
In skeletal muscle
o Increase glucose transport
o Increased glycogenesis
In adipocytes
o Increased glucose transport
o Increased lipogenesis
o Decreased lipolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is glycogenesis?

A

Synthesis of glucose polymer “animal starch”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is glycogenolysis?

A

Breakdown of glycogen in the liver to release glucose when levels are too low.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is lipogenesis?

A

In times of glucose sufficiency, acetyl CoA is used to synthesise fatty acids. These are esterified with glycerol to form triglycerides.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is lipolysis?

A

In times of glucose depletion, the breakdown of triglycerides to produce free fatty acids (FFA).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the evolution of type two diabetes?

A

Includes loss of insulin sensitivity and/or loss of insulin production through beta cells. Early stages characterised by increasing blood glucose levels. Often asymptomatic. Insulin levels become abnormally high as pancreas responds to glucose. Later insulin levels progressively fall as b cell mass and productivity fall off and hyperglycaemia ensues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the initial event of type two diabetes?

A

Loss of response to insulin signalling “insulin resistance.” Glucose remains high - driving increased insulin production by b cells. Initially the increased insulin production maintains (or almost) normal glucose levels. Beta cell mass and productivity fall away and insulin levels progressively fall until glucose levels are uncontrolled. Typically patients need exogenous insulin after 7-8 years.

24
Q

How is diabetes diagnosed usually?

A

When blood glucose levels become so low symptoms of hyperglycaemia occurs.

25
Q

What are glucose meters?

A

Engineered forms of “glucose oxidase” coupled to test strip. FAD-glucose dehydrogenase is used. Chemical electron acceptors contained in an electrode re-oxidise FAD and generate an electrical current.

26
Q

How does loss of insulin affect adipose tissue?

A

– Lipolysis not inhibited by insulin
– Increase of free fatty acids into the circulation

27
Q

How does loss of insulin affect the liver?

A

– Processes free fatty acids to increase triglycerides
– Lipid in the blood increases in the form of LDL and HDL
– LDL Low density lipoprotein
– HDL High density lipoprotein
– Circulating lipids associated with increased risk of atherosclerosis
– Gluconeogenesis can be active even with high circulating glucose concentrations

28
Q

What is the effect of insulin resistance?

A

Persistent high levels of insulin cause the Akt signalling pathway to become refractory.
Effect of persistent high free fatty acids on pathway signalling.
Low level inflammation produced by visceral fat.

29
Q

What is the effects of beta cell depletion?

A

Glucotoxicity
* Persistent high levels of glucose cause apoptosis and loss of b cells
Fatty acids
* High levels of circulating fatty acid associated with glucose insensitivity
Amyloid
* Beta cells in advanced type 2 DM show the presence of abnormal protein aggregates
* These lead to loss of function and cell death
* Aggregates formed from normal cellular protein
* Islet Amyloid Polypeptide (IAPP)
* Co-expressed with insulin
* Shares common promoter regulatory motifs

30
Q

How did Willy Gepts discover the pathogenicity of Type 1 diabetes?

A

Analysed sections of the pancreas from young people with diabetes. Observed infiltrates of lymphocytes and labelled it “insulinitis”

31
Q

What was the effect of Willy Gepts work?

A

There was strong evidence for an autoimmune origin of type 1 diabetes through an overreaction from T lymphocytes.

32
Q

What are the high affinity autoantibodies against beta cells?

A
  • Glutamic acid decarboxylase GAD
  • Insulin IAA
  • Zinc transporter 8 ZnT8
  • Insulin-associated antigen-2 IA-2
33
Q

When can detection of autoantibodies be detected in the pancreas?

A

These autoantibodies can be detected in children from the age of 9 months! Detection of these autoantibodies usually forecasts the development of Type 1 DM in adolescence.

34
Q

Why do patients exhibit insulinitis before symtpoms develop?

A

Beta cella are silently destroyed and insulin production fades. Only when symptoms appear is the diagnosis made.

35
Q

What are the pathologies associated with both type 1 and 2 diabetes?

A
  • Polyuria
  • Neuropathy
  • Macrovascular
  • Microvascular
  • Infection
36
Q

What are microvascular complications associated with diabetes?

A

High glucose concentrations are toxic to endothelial cells lining the capillaries. Induce expression of fibrinogenic growth factors PDGF - platelet derived growth and factor TGF-b - transforming growth factor beta. These increase deposition of matrix in basement membrane, cause thickening of vessel wall and loss of elasticity in vessel and cause loss of circulation and ischaemia. Called a scarring response. Causes gangrene and poor circulation.

37
Q

What are macrovascular complications associated with diabetes?

A

Pathological effects of prolonged high glucose concentrations increase permeability of endothelial cell lining of arteries. Increased circulating LDL and can lead to deposition of lipids in the supportive layers of the vessel. Causes a 3 fold increase of Atheroma and Coronary Artery Disease.

38
Q

What is the neuropathy associated with diabetes?

A

Progressive loss of nerve function generally in the periphery associated with prolonged poor control of glucose levels. Causes are uncertain it could be glucose toxicity to nerve cells or maybe microvascular complications - poor perfusion and death of neurons. Causes tingling, pain, loss of sensation, erectile dysfunction and other problems related to infection and microvascular problems. The dulling of feeling means that damage is unnoticed and bacteria/fungi can infect and damage the whole body.

39
Q

What are the infections associated with diabetes?

A

High levels of tissue glucose provide good habitat for microorganisms. Reduced microvascular function changes the nature of the normal inflammatory response:
* reduced diffusion of normal inflammatory mediators
* reduced migration of immune cells
Peripheral neuropathy can reduce awareness of damage.
Type one diabetes can cause acute weight loss despite hyperphagia, high levels of circulating calories, absolute loss of insulin means that glucose cannot be efficiently used. Other sources of energy are consumed despite high levels of available glucose such as fat and muscle mass.

40
Q

How were initial genetic studies completed for diabetes?

A

Early studies used genetic studies of monozygotic twins as genetically identical. There was in an increase in heritability from 40% to 60%.

41
Q

What did Simpson NE suggest for diabetes genetics?

A

A multifactorial basis for diabetes and postulated that diabetes with an early onset was a different disease. The picture became more complex when a third variant was described. Maturity Onset Diabetes of the Young or MODY (rare autosomal mutations). A small proportion of non-autoimmune diabetes (~ 5%).

42
Q

What is affected through genetic mutations to cause diabetes?

A
  • Calpain 10 – CAPN10 Protease = associated with insulin release from pancreas cells
  • Glucokinase – GCK Hexokinase IV = glucose sensing
  • Glucose Transporter – GLUT2 = Transports glucose into the cell. Gene variants may disrupt glucose regulation.
43
Q

What can understanding the risk factors of type 1 diabetes lead to?

A
  • general insights into the pathogenesis of other autoimmunities
  • lead to screening for those at increased risk
  • suggest ways to intervene in the early stages
44
Q

What are the differences between type 1 and type 2 diabetes?

A

Type 1:
- Juvenile onset
- Requires insulin
- No obesity
- Familial
- MZ concordance 30%
Associated with HLA DR3&DR4

Type 2:
- Mature onset
- Oral hypoglycemic
- Associated with obesity
- Familial
- MZ concordance 40-100%
- No HLA association

45
Q

What are NOD mice?

A

Non obese diabetic mice are experimental animals that can be a very useful genetic disease. Phenotype is very well characterised. Genetics well characterised also - (mice and rats). As there are a number of inbred strains it reduces genetic variability and enables powerful genetic analysis. Also easy to breed large numbers.

46
Q

How are NOD mice used in diabetes?

A

Spontaneously develops type 1 diabetes in 90% of females. Features mirror those of human disease: Insulinitis, Autoantibodies and Progressive loss of beta cells. Hypothesis - the risk loci identified are likely to be reflected in humans.
By crossing to other mouse strains it was possible to identify genetic loci that determined susceptibility to T1DM. Initially the association with the HLA region was confirmed (MHC in mice!). Other loci of lesser affect were rapidly identified Nomenclature: Idd-1, Idd-2, Idd-3 etc.

47
Q

What is MHC IDD-2 in diabetes?

A

Different alleles (with differing number of repeats). Some alleles protective, some increase risk of T1DM. Reduced expression of insulin associated with increased risk. Risk alleles have been associated with reduced expression has been demonstrated in the thymus.

48
Q

What is MHC IDD-4 in diabetes?

A

Locus associated with an aberrant overexpression of IFN (interferon) response to viral infection in the NOD mouse.

49
Q

What is MHC IDD-3 in diabetes?

A

Interleukin-2 (IL-2) is the key regulatory cytokine for T-cells. IL-2 is necessary for the generation and survival of Tregs - the suppressive T cell population. Studies suggest NOD idd3 mice possess less effective Treg populations.

50
Q

What is MHC IDD-5 in diabetes?

A

CTLA-4 is a key regulator of the T cell antigen response. We saw last time how T cell antigen receptor (TCR) activation requires not only MHC by the engagement of co-receptors. Some of these co-receptors positively drive the T cell response. Others exert a counter-negative effect with CTLA-4 acting to dampen the TCR response.

51
Q

What is MHC IDD-18 in diabetes?

A

PTPN22 is a tyrosine phosphatase. Reverses action of tyrosine kinase. Expressed mainly in lymphocytes. Important in shutting down the tyrosine kinase pathways activate by antigen binding in both T and B cells.

52
Q

Are NOD mice actually useful for diabetes?

A

With advances in genomic analysis - SNPs - GWAS, genomic sequencing etc. many of the NOD risk loci have been confirmed in human genetic analyses. This includes CTLA-4 (Risk factor for a number of human autoimmune conditions), T1DM (Autoimmune thyroid disease, rheumatoid arthritis and others), PTPM22 (Also significant risk factor for a number of human autoimmune conditions), T1DM (Autoimmune thyroid disease). Recent studies are developing evidence to support a role for IDD-4 in human T1DM and also identified protective alleles. Supportive evidence for the role of viral infection in T1DM is accumulating.

53
Q

How can beta cells be artificially cultivated and transplanted?

A
  • Primary beta cells or stem cell derived
  • Infused into the liver
  • Beta cells are able to sense blood glucose and response appropriately
  • Better glucose control than exogenous insulin
  • Still experimental only
54
Q

What are problems with cultiavting artifical beta cells?

A

Problems include that the patient is still autoimmune and beta cells are destroyed over time. Can use immunosuppressant’s such as cyclosporine but these have dangerous side effects with long term use and can lead to infection and tumour development.

55
Q

How can we artificially induce tolerance?

A

This is done by introducing high doses of antigen in absence of danger signals. There are no second signals of infection resulting in anergy in antigen specific T cells. Experiments are ongoing with animal studies with promising results with insulin as an antigen. There is no data in humans.

56
Q

How can we possibly reset the adaptive immune repertoire?

A

Before treatment the patient’s lymphopoetic stem cells are harvested from the bone marrow. Re-introduced after treatment and use to seed and re-establish the immune system. Analysis shows that diversity of T and B cells in unaffected and a full repertoire is developed once more. Patients with MS have shown remarkable degree of remission following transplants. The immune repertoire appears to have been reset. Potentially a new and effective treatment.